Quest Diagnostics

When researching Quest Diagnostics, analysts typically begin with its Health Care sector positioning and Health Care Services industry dynamics. Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

The company reports trailing twelve-month revenue of $2.90B and net income of $252.00M. Key metrics include a return on equity of 3.4%.

FINOTAUR provides free research summaries, news aggregation, and fundamentals for DGX to support both active traders and long-term investors.